Abstract
It is ironic that the p53 “tumor antigen”, first discovered more than 20 years ago, was initially thought to play a major role in promoting tumorigenesis (Parada et al. 1984). It was not long after, however, that the p53 protein was found to be a potent tumor suppressor. In fact, since the mid1990s, p53 has been regarded as the “guardian of the genome” on the basis of its ability to block the proliferation of cells with mutated DNA (Lane 1992). For more than two decades, tumor suppressor p53 has been among the most widely studied proteins. Notably, the myriad cellular functions in which p53 is involved continue to increase (Levine et al. 2006; Efeyan and Serrano 2007; Fuster et al. 2007).
The human p53 protein consists of 393 amino acid residues and has a molecular weight of approximately 53 kDa. The p53 gene product is a modular molecule that consists of three well-characterized functional domains: an N-terminal transactivation domain (residues 1–42), a central sequence-specific DNA binding domain (residues 102–292), and a highly basic C-terminal domain that regulates p53 oligomerization and sequence-specific DNA binding (Fig. 15.1) (Prives and Hall 1999; Lavin and Gueven 2006).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Appella E, Anderson CW (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268:2764–2772
Bengzon J, Mohapel P, Ekdahl CT, Lindvall O (2002) Neuronal apoptosis after brief and prolonged seizures. Prog Brain Res 135:111–119
Bischof O, Schwamborn K, Martin N, Werner A, Sustmann C, Grosschedl R, Dejean A (2006) The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell 22:783–794
Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: The molecular basis for p53 regulation. Curr Opin Cell Biol 15:164–171
Brooks CL, Gu W (2004) Dynamics in the p53-Mdm2 ubiquitination pathway. Cell Cycle 3:895–899
Byrnes KR, Faden AI (2007) Role of cell cycle proteins in CNS injury. Neurochem Res 32:1799–1807
Chipuk JE, Green DR (2004) Cytoplasmic p53: Bax and forward. Cell Cycle 3:429–431
Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS, Slack RS (1999) Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. J Neurosci 19:7860–7869
Culmsee C, Mattson MP (2005) p53 in neuronal apoptosis. Biochem Biophys Res Commun 331:761–777
Culmsee C, Zhu X, Yu QS, Chan SL, Camandola S, Guo Z, Greig NH, Mattson MP (2001) A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem 77:220–228
Deb SP (2002) Function and dysfunction of the human oncoprotein MDM2. Front Biosci 7:d235–d243
Djebaïli M, Lerner-Natoli M, Montpied P, Baille V, Bockaert J, Rondouin G (2001) Molecular events involved in neuronal death induced in the mouse hippocampus by in-vivo injection of kainic acid. Brain Res Mol Brain Res 93:190–198
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–221
Efeyan A, Serrano M (2007) p53: Guardian of the genome and policeman of the oncogenes. Cell Cycle 6:1006–1010
El-Hodhod MA, Tomoum HY, Abd Al-Aziz MM, Samaan SM (2006) Serum Fas and Bcl-2 in patients with epilepsy. Acta Neurol Scand 113:315–321
Endo H, Saito A, Chan PH (2006) Mitochondrial translocation of p53 underlies the selective death of hippocampal CA1 neurons after global cerebral ischaemia. Biochem Soc Trans 34:1283–1286
Engel T, Murphy BM, Schindler CK, Henshall DC (2007) Elevated p53 and lower MDM2 expression in hippocampus from patients with intractable temporal lobe epilepsy. Epilepsy Res 77:151–156
Ethell DW, Buhler LA (2003) Fas ligand-mediated apoptosis in degenerative disorders of the brain. J Clin Immunol 23:439–446
Fabene PF, Merigo F, Galiè M, Benati D, Bernardi P, Farace P, Nicolato E, Marzola P, Sbarbati A (2007) Pilocarpine-induced status epilepticus in rats involves ischemic and excitotoxic mechanisms. PLoS One 2:e1105
Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J (2001) Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50:2363–2375
Fogarty MP, Downer EJ, Campbell V (2003) A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons. Biochem J 371:789–798
Fortin A, Cregan SP, MacLaurin JG, Kushwaha N, Hickman ES, Thompson CS, Hakim A, Albert PR, Cecconi F, Helin K, Park DS, Slack RS (2001) APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J Cell Biol 155:207–216
Fujikawa DG (2005) Prolonged seizures and cellular injury: Understanding the connection. Epilepsy Behav 7(Suppl 3):S3–S11
Fuster JJ, Sanz-González SM, Moll UM, Andrés V (2007) Classic and novel roles of p53: Prospects for anticancer therapy. Trends Mol Med 13:192–199
Gilman CP, Chan SL, Guo Z, Zhu X, Greig N, Mattson MP (2003) p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults. Neuromol Med 3:159–172
Giono LE, Manfredi JJ (2006) The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 209:13–20
Henshall DC, Clark RS, Adelson PD, Chen M, Watkins SC, Simon RP (2000) Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 55:250–257
Henshall DC, Bonislawski DP, Skradski SL, Araki T, Lan JQ, Schindler CK, Meller R, Simon RP (2001) Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death. Cell Death Differ 8:1169–1181
Hughes PE, Alexi T, Schreiber SS (1997) Minireview: A role for the tumour-suppressor gene p53 in neuronal apoptosis. NeuroReport 8:v–xi
Iwakuma T, Lozano G, Flores ER (2005) Li-Fraumeni syndrome: A p53 family affair. Cell Cycle 4:865–867
Kurki S, Peltonen K, Laiho M (2004) Nucleophosmin, HDM2 and p53: Players in UV damage incited nucleolar stress response. Cell Cycle 3:976–979
Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358:15–16
Lavin MF, Gueven N (2006) The complexity of p53 stabilization and activation. Cell Death Differ 13:941–950
Lee JH, Kim HS, Lee SJ, Kim KT (2007) Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J Cell Sci 120:2259–2271
Leu JI, Dumont P, Hafey M, Murphy ME, George DL (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6:443–450
Levine AJ, Hu W, Feng Z (2006) The P53 pathway: What questions remain to be explored? Cell Death Differ 13:1027–1036
Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G (2000) The p53/p63/p73 family of transcription factors: Overlapping and distinct functions. J Cell Sci 113:1661–1670
Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W (2003) Mono- versus polyubiquitination: Differential control of p53 fate by Mdm2. Science 302:1972–1975
Liu W, Bi X, Tocco G, Baudry M, Schreiber SS (1996) Increased expression of cyclin D1 in the adult rat brain following kainic acid treatment. Neuroreport 7:2785–2789
Liu W, Rong Y, Baudry M, Schreiber SS (1999) Status epilepticus induces p53 sequence-specific DNA binding in mature rat brain. Brain Res Mol Brain Res 63:248–253
Liu W, Liu R, Chun JT, Bi R, Hoe W, Schreiber SS, Baudry M (2001) Kainate excitotoxicity in organotypic hippocampal slice cultures: Evidence for multiple apoptotic pathways. Brain Res 916:239–248
Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137–148
Mayer C, Grummt I (2005) Cellular stress and nucleolar function. Cell Cycle 4:1036–1038
Meek DW (1997) Post-translational modification of p53 and the integration of stress signals. Pathol Biol (Paris) 45:804–814
Miyashita T, Harigai M, Hanada M, Reed JC (1994) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131–3135
Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA (1996) Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16:1337–1345
Morrison RS, Kinoshita Y, Johnson MD, Guo W, Garden GA (2003) p53-dependent cell death signaling in neurons. Neurochem Res 28:15–27
Murphy ME, Leu JI, George DL (2004) p53 moves to mitochondria: a turn on the path to apoptosis. Cell Cycle 3:836–839
Neema M, Navarro-Quiroga I, Chechlacz M, Gilliams-Francis K, Liu J, Lamonica K, Lin SL, Naegele JR (2005) DNA damage and nonhomologous end joining in excitotoxicity: Neuroprotective role of DNA-PKcs in kainic acid-induced seizures. Hippocampus 15:1057–1071
Ohnishi T (2005) The role of the p53 molecule in cancer therapies with radiation and/or hyperthermia. J Cancer Res Ther 1:147–150
Olsson A, Manzl C, Strasser A, Villunger A (2007) How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 14:1561–1575
Parada LF, Land H, Weinberg RA, Wolf D, Rotter V (1984) Cooperation between gene encoding p53 tumour antigen and Ras in cellular transformation. Nature 312:649–651
Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112–126
Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS (1994) p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci USA 91:7525–7529
Sakhi S, Sun N, Wing LL, Mehta P, Schreiber SS (1996) Nuclear accumulation of p53 protein following kainic acid-induced seizures. Neuroreport 7:493–496
Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS (1997) Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment. Exp Neurol 145:81–88
Schauwecker PE (2003) Genetic basis of kainate-induced excitotoxicity in mice: Phenotypic modulation of seizure-induced cell death. Epilepsy Res 55:201–210
Tan Z, Qu W, Tu W, Liu W, Baudry M, Schreiber SS (2000) Downregulation of free ubi-quitin: A novel mechanism of p53 stabilization and neuronal cell death. Cell Death Differ 27:675–681
Tan Z, Tu W, Schreiber SS (2001a) Downregulation of free ubiquitin: A novel mechanism of p53 stabilization and neuronal cell death. Brain Res Mol Brain Res 91:179–188
Tan Z, Levid J, Schreiber SS (2001b) Increased expression of Fas (CD95/APO-1) in adult rat brain after kainate-induced seizures. Neuroreport 12:1979–1982
Tan Z, Sankar R, Shin D, Sun N, Liu H, Wasterlain CG, Schreiber SS (2002a) Differential induction of p53 in immature and adult rat brain following lithium-pilocarpine status epilepticus. Brain Res 928:187–193
Tan Z, Sankar R, Tu W, Shin D, Liu H, Wasterlain CG, Schreiber SS (2002b) Immunohistochemical study of p53-associated proteins in rat brain following lithium-pilocarpine status epilepticus. Brain Res 929:129–138
Uberti D, Belloni M, Grilli M, Spano P, Memo M (1998) Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Eur J Neurosci 10:246–254
Uo T, Kinoshita Y, Morrison RS (2007) Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/cytoplasmic site of action in postnatal cortical neurons. J Neurosci 27:12198–12210
Vousden KH (2002) Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 1602:47–59
Wang Q, Yu S, Simonyi A, Sun GY, Sun AY (2005) Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol 31:3–16
Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA, Morrison RS (1996) Evidence for p53-mediated modulation of neuronal viability. J Neurosci 16:6753–6765
Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Schwartzkroin PA, Morrison RS (1998) Bax involvement in p53-mediated neuronal cell death. J Neurosci 18:1363–1373
Xu S, Pang Q, Liu Y, Shang W, Zhai G, Ge M (2007) Neuronal apoptosis in the resected sclerotic hippocampus in patients with mesial temporal lobe epilepsy. J Clin Neurosci 14:835–840
Yang Y, Li CC, Weissman AM (2004) Regulating the p53 system through ubiquitination. Oncogene 23:2096–2106
Yang T, Hsu C, Liao W, Chuang JS (2008) Heat shock protein 70 expression in epilepsy suggests stress rather than protection. Acta Neuropathol 115:219–230
Yao X, Liu J, McCabe JT (2007) Ubiquitin and ubiquitin-conjugated protein expression in the rat cerebral cortex and hippocampus following traumatic brain injury (TBI). Brain Res 1182:116–122
Zhai W, Comai L (2000) Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol Cell Biol 20:5930–5938
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tan, Z., Schreiber, S.S. (2010). Tumor Suppressor p53: A Multifunctional Protein Implicated in Seizure-Induced Neuronal Cell Death. In: Fujikawa, D. (eds) Acute Neuronal Injury. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-73226-8_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-73226-8_15
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-73225-1
Online ISBN: 978-0-387-73226-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)